Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00MTG
|
|||
| Former ID |
DNCL003749
|
|||
| Drug Name |
SAR279356
|
|||
| Synonyms |
F598
Click to Show/Hide
|
|||
| Indication | Serious infection [ICD-11: 1H0Z; ICD-10: A00-B99; ICD-9: 001-139] | Phase 2 | [1] | |
| Company |
Sanofi
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Poly-N-acetyl glucosamine (PNAG) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01389700) Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients. U.S. National Institutes of Health. | |||
| REF 2 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.